A Study of 1592U89 in HIV-Infected Patients
NCT00002388
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Abacavir sulfate
Sponsor
Glaxo Wellcome